<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0">
<channel>
<title>News for Integra Lifesciences Holdings Corp - Google Finance</title>
<description>News for Integra Lifesciences Holdings Corp - Google Finance</description>
<link>http://www.google.com/finance?q=NASDAQ:IART&amp;amp;client=news-rss&amp;amp;ei=HtyZUbDjLeug0AGqvwE</link>
<image>
<title>News for Integra Lifesciences Holdings Corp - Google Finance</title>
<url>/finance/s/M4XFgDr56u4/images/logo_us.gif</url>
<link>http://www.google.com/finance?q=NASDAQ:IART&amp;amp;client=news-rss&amp;amp;ei=HtyZUbDjLeug0AGqvwE</link>
</image>
<item>
<title>INTEGRA LIFESCIENCES HOLDINGS CORP : Integra LifeSciences Debuts Next ...</title>
<link>http://www.4-traders.com/INTEGRA-LIFESCIENCES-HOLD-9608/news/Integra-Lifesciences-Holdings-Corp-Integra-LifeSciences-Debuts-Next-Generation-Camino-R-Platform-16797439/</link>
<guid isPermaLink="false">tag:finance.google.com,cluster:52778137916032</guid>
<pubDate>Mon, 29 Apr 2013 13:28:02 GMT</pubDate>
<description>
&lt;div style=&quot;padding:0px; margin-bottom:1.5em;&quot;&gt;
&lt;a href=&quot;http://www.4-traders.com/INTEGRA-LIFESCIENCES-HOLD-9608/news/Integra-Lifesciences-Holdings-Corp-Integra-LifeSciences-Debuts-Next-Generation-Camino-R-Platform-16797439/&quot; style=&quot;font-size:1.2em&quot;&gt;INTEGRA LIFESCIENCES HOLDINGS CORP : Integra LifeSciences Debuts Next ...&lt;/a&gt;
&lt;br&gt; &lt;span style=&quot;color:#888888;&quot;&gt;4-traders (press release)&lt;/span&gt; - &lt;span style=&quot;white-space:nowrap&quot;&gt;Apr 29, 2013 &lt;/span&gt;
&lt;div style=&quot;width:80%;&quot;&gt;PLAINSBORO, N.J., April 29, 2013 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (Nasdaq:IART) today announced the debut of the next generation of the Camino® platform, an advanced monitoring system for continuous intracranial ...&lt;/div&gt;
&lt;a href=&quot;http://www.globenewswire.com/news-release/2013/04/29/542461/10030366/en/Integra-LifeSciences-Launches-Integra-R-Compact-Cranial-Closure-System.html&quot;&gt;Integra LifeSciences Launches Integra(R) Compact Cranial Closure System&lt;/a&gt; - &lt;span style=&quot;color:#888888&quot;&gt;GlobeNewswire (press release)&lt;/span&gt;&lt;br&gt;
&lt;/div&gt;
</description>
</item>
<item>
<title>INTEGRA LIFESCIENCES HOLDINGS CORP : Integra LifeSciences Reports ...</title>
<link>http://www.4-traders.com/INTEGRA-LIFESCIENCES-HOLD-9608/news/Integra-Lifesciences-Holdings-Corp-Integra-LifeSciences-Reports-First-Quarter-2013-Financial-Resul-16806121/</link>
<guid isPermaLink="false">tag:finance.google.com,cluster:52778141118657</guid>
<pubDate>Thu, 02 May 2013 10:23:19 GMT</pubDate>
<description>
&lt;div style=&quot;padding:0px; margin-bottom:1.5em;&quot;&gt;
&lt;a href=&quot;http://www.4-traders.com/INTEGRA-LIFESCIENCES-HOLD-9608/news/Integra-Lifesciences-Holdings-Corp-Integra-LifeSciences-Reports-First-Quarter-2013-Financial-Resul-16806121/&quot; style=&quot;font-size:1.2em&quot;&gt;INTEGRA LIFESCIENCES HOLDINGS CORP : Integra LifeSciences Reports ...&lt;/a&gt;
&lt;br&gt; &lt;span style=&quot;color:#888888;&quot;&gt;4-traders (press release)&lt;/span&gt; - &lt;span style=&quot;white-space:nowrap&quot;&gt;May 2, 2013 &lt;/span&gt;
&lt;div style=&quot;width:80%;&quot;&gt;PLAINSBORO, N.J., May 2, 2013 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (Nasdaq:IART) today reported its financial results for the first quarter ending March 31, 2013.&lt;/div&gt;
&lt;a href=&quot;http://www.nasdaq.com/article/integra-lifesciences-holdings-q1-13-earnings-conference-call-at-830-am-et-20130502-00333&quot;&gt;Integra Lifesciences Holdings Q1 13 Earnings Conference Call At 8:30 AM ET&lt;/a&gt; - &lt;span style=&quot;color:#888888&quot;&gt;NASDAQ&lt;/span&gt;&lt;br&gt;
&lt;a href=&quot;http://www.rttnews.com/2107968/integra-lifesciences-turns-to-loss-in-q1-quick-facts.aspx?type=ern&quot;&gt;Integra LifeSciences Turns To Loss In Q1 - Quick Facts - RTTNews&lt;/a&gt; - &lt;span style=&quot;color:#888888&quot;&gt;RTT News&lt;/span&gt;&lt;br&gt;
&lt;/div&gt;
</description>
</item>
<item>
<title>INTEGRA LIFESCIENCES HOLDINGS CORP : Integra LifeSciences Introduces ...</title>
<link>http://www.4-traders.com/INTEGRA-LIFESCIENCES-HOLD-9608/news/Integra-Lifesciences-Holdings-Corp-Integra-LifeSciences-Introduces-Hollywood-TM-VI-Spinal-Fusion-16800885/</link>
<guid isPermaLink="false">tag:finance.google.com,cluster:52778139343513</guid>
<pubDate>Tue, 30 Apr 2013 13:27:35 GMT</pubDate>
<description>
&lt;div style=&quot;padding:0px; margin-bottom:1.5em;&quot;&gt;
&lt;a href=&quot;http://www.4-traders.com/INTEGRA-LIFESCIENCES-HOLD-9608/news/Integra-Lifesciences-Holdings-Corp-Integra-LifeSciences-Introduces-Hollywood-TM-VI-Spinal-Fusion-16800885/&quot; style=&quot;font-size:1.2em&quot;&gt;INTEGRA LIFESCIENCES HOLDINGS CORP : Integra LifeSciences Introduces ...&lt;/a&gt;
&lt;br&gt; &lt;span style=&quot;color:#888888;&quot;&gt;4-traders (press release)&lt;/span&gt; - &lt;span style=&quot;white-space:nowrap&quot;&gt;Apr 30, 2013 &lt;/span&gt;
&lt;div style=&quot;width:80%;&quot;&gt;PLAINSBORO, N.J., April 30, 2013 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (Nasdaq:IART) today announced the full market release of its HollywoodTM VI intervertebral body fusion device (IBD) system.&lt;/div&gt;
&lt;/div&gt;
</description>
</item>
<item>
<title>Integra LifeSciences to Participate in Investor Conferences in May</title>
<link>http://www.globenewswire.com/news-release/2013/05/07/545064/10031686/en/Integra-LifeSciences-to-Participate-in-Investor-Conferences-in-May.html</link>
<guid isPermaLink="false">tag:finance.google.com,cluster:52778146964184</guid>
<pubDate>Tue, 07 May 2013 12:32:50 GMT</pubDate>
<description>
&lt;div style=&quot;padding:0px; margin-bottom:1.5em;&quot;&gt;
&lt;a href=&quot;http://www.globenewswire.com/news-release/2013/05/07/545064/10031686/en/Integra-LifeSciences-to-Participate-in-Investor-Conferences-in-May.html&quot; style=&quot;font-size:1.2em&quot;&gt;Integra LifeSciences to Participate in Investor Conferences in May&lt;/a&gt;
&lt;br&gt; &lt;span style=&quot;color:#888888;&quot;&gt;GlobeNewswire (press release)&lt;/span&gt; - &lt;span style=&quot;white-space:nowrap&quot;&gt;May 7, 2013 &lt;/span&gt;
&lt;div style=&quot;width:80%;&quot;&gt;... information, future events or otherwise. Integra LifeSciences Holdings Corporation John B. Henneman, III Corporate Vice President, Finance and Administration and Chief Financial Officer (609) 275-0500 Investor Relations: Angela Steinway (609) 936 ...&lt;/div&gt;
&lt;/div&gt;
</description>
</item>
<item>
<title>Integra LifeSciences Downgraded by TheStreet to &amp;quot;Hold&amp;quot; (IART)</title>
<link>http://www.mideasttime.com/integra-lifesciences-downgraded-by-thestreet-to-hold-iart/16908/</link>
<guid isPermaLink="false">tag:finance.google.com,cluster:52778145685033</guid>
<pubDate>Mon, 06 May 2013 10:22:59 GMT</pubDate>
<description>
&lt;div style=&quot;padding:0px; margin-bottom:1.5em;&quot;&gt;
&lt;a href=&quot;http://www.mideasttime.com/integra-lifesciences-downgraded-by-thestreet-to-hold-iart/16908/&quot; style=&quot;font-size:1.2em&quot;&gt;Integra LifeSciences Downgraded by TheStreet to &amp;quot;Hold&amp;quot; (IART)&lt;/a&gt;
&lt;br&gt; &lt;span style=&quot;color:#888888;&quot;&gt;Mideast Time&lt;/span&gt; - &lt;span style=&quot;white-space:nowrap&quot;&gt;May 6, 2013 &lt;/span&gt;
&lt;div style=&quot;width:80%;&quot;&gt;The analysts wrote, “Integra LifeSciences Holdings (IART) has been downgraded by TheStreet Ratings from buy to hold. The company&amp;#39;s strengths can be seen in multiple areas, such as its revenue growth, expanding profit margins and notable return on ...&lt;/div&gt;
&lt;a href=&quot;http://www.dailyfinance.com/2013/05/06/integra-lifesciences-holdings-goes-negative/&quot;&gt;Integra LifeSciences Holdings Goes Negative&lt;/a&gt; - &lt;span style=&quot;color:#888888&quot;&gt;DailyFinance&lt;/span&gt;&lt;br&gt;
&lt;/div&gt;
</description>
</item>
<item>
<title>Integra LifeSciences Price Target Lowered to $39.00 at RBC Capital (IART)</title>
<link>http://zolmax.com/integra-lifesciences-price-target-lowered-to-39-00-at-rbc-capital-iart/65314/</link>
<guid isPermaLink="false">tag:finance.google.com,cluster:http://zolmax.com/integra-lifesciences-price-target-lowered-to-39-00-at-rbc-capital-iart/65314/</guid>
<pubDate>Mon, 13 May 2013 21:43:24 GMT</pubDate>
<description>
&lt;div style=&quot;padding:0px; margin-bottom:1.5em;&quot;&gt;
&lt;a href=&quot;http://zolmax.com/integra-lifesciences-price-target-lowered-to-39-00-at-rbc-capital-iart/65314/&quot; style=&quot;font-size:1.2em&quot;&gt;Integra LifeSciences Price Target Lowered to $39.00 at RBC Capital (IART)&lt;/a&gt;
&lt;br&gt; &lt;span style=&quot;color:#888888;&quot;&gt;Zolmax&lt;/span&gt; - &lt;span style=&quot;white-space:nowrap&quot;&gt;May 13, 2013 &lt;/span&gt;
&lt;div style=&quot;width:80%;&quot;&gt;Integra LifeSciences has set its FY13 guidance at $2.40-2.70 EPS. Analysts expect that Integra LifeSciences will post $2.49 EPS for the current fiscal year.&lt;/div&gt;
&lt;/div&gt;
</description>
</item>
<item>
<title>Integra LifeSciences Downgraded to &amp;quot;Underperform&amp;quot; at Zacks (IART)</title>
<link>http://www.mideasttime.com/integra-lifesciences-downgraded-to-underperform-at-zacks-iart/12944/</link>
<guid isPermaLink="false">tag:finance.google.com,cluster:http://www.mideasttime.com/integra-lifesciences-downgraded-to-underperform-at-zacks-iart/12944/</guid>
<pubDate>Wed, 24 Apr 2013 18:47:16 GMT</pubDate>
<description>
&lt;div style=&quot;padding:0px; margin-bottom:1.5em;&quot;&gt;
&lt;a href=&quot;http://www.mideasttime.com/integra-lifesciences-downgraded-to-underperform-at-zacks-iart/12944/&quot; style=&quot;font-size:1.2em&quot;&gt;Integra LifeSciences Downgraded to &amp;quot;Underperform&amp;quot; at Zacks (IART)&lt;/a&gt;
&lt;br&gt; &lt;span style=&quot;color:#888888;&quot;&gt;Mideast Time&lt;/span&gt; - &lt;span style=&quot;white-space:nowrap&quot;&gt;Apr 24, 2013 &lt;/span&gt;
&lt;div style=&quot;width:80%;&quot;&gt;Integra LifeSciences Holdings Corporation (NASDAQ: IART) is an integrated medical device company. To view Zacks&amp;#39; full report, visit www.&lt;/div&gt;
&lt;/div&gt;
</description>
</item>
<item>
<title>Integra LifeSciences Lowered to Underperform at Zacks (IART)</title>
<link>http://utahpeoplespost.com/2013/04/integra-lifesciences-lowered-to-underperform-at-zacks-iart/</link>
<guid isPermaLink="false">tag:finance.google.com,cluster:52778133194417</guid>
<pubDate>Fri, 26 Apr 2013 19:34:59 GMT</pubDate>
<description>
&lt;div style=&quot;padding:0px; margin-bottom:1.5em;&quot;&gt;
&lt;a href=&quot;http://utahpeoplespost.com/2013/04/integra-lifesciences-lowered-to-underperform-at-zacks-iart/&quot; style=&quot;font-size:1.2em&quot;&gt;Integra LifeSciences Lowered to Underperform at Zacks (IART)&lt;/a&gt;
&lt;br&gt; &lt;span style=&quot;color:#888888;&quot;&gt;The Utah People&#39;s Post&lt;/span&gt; - &lt;span style=&quot;white-space:nowrap&quot;&gt;Apr 26, 2013 &lt;/span&gt;
&lt;div style=&quot;width:80%;&quot;&gt;Integra LifeSciences has a 52 week low of $30.87 and a 52 week high of $44.53. The stock&amp;#39;s 50-day moving average is currently $38.10.&lt;/div&gt;
&lt;/div&gt;
</description>
</item>
<item>
<title>Disappointing 1Q Earnings for IART - Analyst Blog - NASDAQ.com</title>
<link>http://www.nasdaq.com/article/disappointing-1q-earnings-for-iart-analyst-blog-cm245205</link>
<guid isPermaLink="false">tag:finance.google.com,cluster:52778148220689</guid>
<pubDate>Fri, 10 May 2013 15:28:28 GMT</pubDate>
<description>
&lt;div style=&quot;padding:0px; margin-bottom:1.5em;&quot;&gt;
&lt;a href=&quot;http://www.nasdaq.com/article/disappointing-1q-earnings-for-iart-analyst-blog-cm245205&quot; style=&quot;font-size:1.2em&quot;&gt;Disappointing 1Q Earnings for IART - Analyst Blog - NASDAQ.com&lt;/a&gt;
&lt;br&gt; &lt;span style=&quot;color:#888888;&quot;&gt;NASDAQ&lt;/span&gt; - &lt;span style=&quot;white-space:nowrap&quot;&gt;May 10, 2013 &lt;/span&gt;
&lt;div style=&quot;width:80%;&quot;&gt;Integra LifeSciences Holdings Corp. ( IART ) reported adjusted earnings per share (EPS) of 39 cents in the first quarter of 2013, declining 45.1% from the year-ago quarter, as well as below the Zacks Consensus Estimate of 48 cents by 18.9%.&lt;/div&gt;
&lt;/div&gt;
</description>
</item>
<item>
<title>DIARY-NON S&amp;amp;P WEEK AHEAD</title>
<link>http://www.reuters.com/article/2013/05/02/diary-non-sp-week-idUSL3N0DJ21D20130502</link>
<guid isPermaLink="false">tag:finance.google.com,cluster:52778141302422</guid>
<pubDate>Thu, 02 May 2013 09:13:06 GMT</pubDate>
<description>
&lt;div style=&quot;padding:0px; margin-bottom:1.5em;&quot;&gt;
&lt;a href=&quot;http://www.reuters.com/article/2013/05/02/diary-non-sp-week-idUSL3N0DJ21D20130502&quot; style=&quot;font-size:1.2em&quot;&gt;DIARY-NON S&amp;amp;P WEEK AHEAD&lt;/a&gt;
&lt;br&gt; &lt;span style=&quot;color:#888888;&quot;&gt;Reuters&lt;/span&gt; - &lt;span style=&quot;white-space:nowrap&quot;&gt;May 2, 2013 &lt;/span&gt;
&lt;div style=&quot;width:80%;&quot;&gt;OF YEAR AGO ESTIMATE EST EPS 02 May BMO Q1 2013 Atlas Air Worldwide Holdings Inc 0.15 10 0.51 02 May BMO Q4 2013 Abiomed, Inc. 0.07 11 0.06 02 May AMC Q1 2013 Autobytel Inc. 0.04 4 0.15 02 May BMO Q1 2013 ACI Worldwide, Inc. 0.33 7 -0.05 ...&lt;/div&gt;
&lt;/div&gt;
</description>
</item>
</channel>
</rss>
